Company

Ablative Solutions

Rocket Ship Rating

Rocket Ship Rating: 97 out of 100

Pioneering Targeted Perivascular Therapy

Also known as ABLATIVE SOLUTIONS Inc., ablativesolutions

Medical devices & diagnostics

Status: Operatingas of 2026-09-18
Business model: B2B
Headquarters: San Jose, CA, United States
Legal name: ABLATIVE SOLUTIONS Inc.

ablativesolutions.com (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Transcatheter renal denervation for hypertension.

Funding snapshot

Total raised: $180MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $10.4M2025-11-14

Funding rounds

Round, 2025: $10.4M2025-11-14, SEC form D sold, 10 investors
Round, 2024: $37.2M2024-12-18, SEC form D sold, 88 investors
Round, 2023: $29.3M2023-03-31, SEC form D sold, 121 investors
Round, 2018: $54.5M2018-12-28, SEC form D sold, 105 investors
Round, 2017: $4M2017-12-20, SEC form D sold, 24 investors
Round, 2017: $11.4M2017-02-21, SEC form D sold, 88 investors
Round, 2015: $2.5M2015-10-30, SEC form D sold, 24 investors
Round, 2013: $14.6M2013-12-30, SEC form D sold, 149 investors
Round, 2013: $8M2013-03-26, SEC form D sold, 98 investors
Round, 2012: $5.4M2012-06-14, SEC form D sold, 72 investors
Round, 2012: $9902012-02-01, SEC form D sold, 1 investor
Round, 2012: $5002012-01-11, SEC form D sold, 1 investor
Round, 2011: $5K2011-12-15, SEC form D sold, 2 investors
Round, 2011: $3.1M2011-11-17, SEC form D sold, 64 investors